Global

Current Studies

All
Bleeding Disorders
Hereditary Angioedema
Immunoglobulins
Perioperative Bleeding
Pulmonary
Therapeutic Proteins


Condition Additional Trial Information

Hemophilia A With Inhibitors
Hemophilia B With Inhibitors

Study of Recombinant Factor VIIa Fusion Protein (rVIIa-FP, CSL689) for On-demand Treatment of Bleeding Episodes in Patients With Hemophilia A or B With Inhibitors

> Learn More

Congenital Fibrinogen Deficiency

An Observational Cohort Study of the Safety and Efficacy of Fibrinogen Concentrate, Human (FCH) in Subjects With Congenital Fibrinogen Deficiency

> Learn More

Antibody-mediated kidney transplant rejection

Efficacy and Safety of Human Plasma-derived C1-esterase Inhibitor as add-on to Standard of Care for the Treatment of Refractory Antibody Mediated Rejection (AMR) in Adult Renal Transplant Recipients

> Learn More

Other inflammatory or immune system disorders

Dose escalation, placebo-controlled phase 1 study to assess the safety and tolerability of CSL324 in healthy adults

> Learn More

Primary Immune Deficiency

Study of Immune Deficiency Patients Treated With Subcutaneous Immunoglobulin (IgPro20, Hizentra®) on Weekly and Biweekly Schedules

> Learn More

Page 2 of 3 First | Last
Share
LinkedIn Twitter Facebook Google+